140 related articles for article (PubMed ID: 37118924)
1. Implementation of Quitline Financial Incentives to Increase Counseling Sessions Among Adults Who Use Menthol Tobacco Products.
Bourne DE; Williams R; Osbahr L; Roemhildt M; Villanti AC
Health Promot Pract; 2024 Mar; 25(2):167-169. PubMed ID: 37118924
[TBL] [Abstract][Full Text] [Related]
2. Racial/Ethnic Differences in the Response to Incentives for Quitline Engagement.
Vijayaraghavan M; Dove MS; Stewart SL; Cummins SE; Schillinger D; Kohatsu ND; Tong EK
Am J Prev Med; 2018 Dec; 55(6 Suppl 2):S186-S195. PubMed ID: 30454673
[TBL] [Abstract][Full Text] [Related]
3. Impact of Smoking Cessation Motivations and Barriers on Quit Intentions Following a Hypothetical Flavor Ban Among African American/Black Individuals Who Use Menthol Cigarettes: A Mixed-Methods Study.
White AM; Patev AJ; Imran R; Goden A; Rudy AK; Bajwa H; Guy MC; Hood K; Cobb CO; Barnes AJ
Nicotine Tob Res; 2024 May; 26(Supplement_2):S121-S132. PubMed ID: 38817032
[TBL] [Abstract][Full Text] [Related]
4. Feasibility and Early Outcomes of a Tailored Quitline Protocol for Smokers With Mental Health Conditions.
Carpenter KM; Nash CM; Vargas-Belcher RA; Vickerman KA; Haufle V
Nicotine Tob Res; 2019 Apr; 21(5):584-591. PubMed ID: 30768203
[TBL] [Abstract][Full Text] [Related]
5. The Medi-Cal Incentives to Quit Smoking Project: Impact of Statewide Outreach Through Health Channels.
Tong EK; Stewart SL; Schillinger D; Vijayaraghavan M; Dove MS; Epperson AE; Vela C; Kratochvil S; Anderson CM; Kirby CA; Zhu SH; Safier J; Sloss G; Kohatsu ND
Am J Prev Med; 2018 Dec; 55(6 Suppl 2):S159-S169. PubMed ID: 30454670
[TBL] [Abstract][Full Text] [Related]
6. Reactions to hypothetical flavor bans among current users of flavored e-cigarettes.
Yang Y; Lindblom EN; Ward KD; Salloum RG
Transl Behav Med; 2023 Aug; 13(8):533-538. PubMed ID: 36694931
[TBL] [Abstract][Full Text] [Related]
7. Racial and Ethnic Differences in Initiation of Menthol Tobacco Smoking and Subsequent Tobacco Use in the Population Assessment of Tobacco and Health Study, Waves 1-4 (2013-2018).
Yan X; Salloum RG; Leong MC; Khalil GE; Lee JH; Lou XY
Nicotine Tob Res; 2023 Jul; 25(8):1440-1446. PubMed ID: 37058132
[TBL] [Abstract][Full Text] [Related]
8. Financial IncEntives for Smoking TreAtment: protocol of the FIESTA trial and FIESTA Oral Microbiome Substudy.
French KM; Gonzalez SZ; Sherman SE; Link AR; Malik SZ; Tseng CH; Jumkhawala SA; Tejada B; White A; Ladapo JA
Trials; 2018 Nov; 19(1):646. PubMed ID: 30463608
[TBL] [Abstract][Full Text] [Related]
9. Comparing the New York State Smokers' Quitline Reach, Services Offered, and Quit Outcomes to 44 Other State Quitlines, 2010 to 2015.
Mann N; Nonnemaker J; Chapman L; Shaikh A; Thompson J; Juster H
Am J Health Promot; 2018 Jun; 32(5):1264-1272. PubMed ID: 28805074
[TBL] [Abstract][Full Text] [Related]
10. Marijuana Use and Adherence to Smoking Cessation Treatment Among Callers to Tobacco Quitlines.
Carpenter KM; Torres AJ; Salmon EE; Carlini BH; Vickerman KA; Schauer GL; Bush T
Prev Chronic Dis; 2020 Sep; 17():E102. PubMed ID: 32915131
[TBL] [Abstract][Full Text] [Related]
11. Utilizing Reach Ratios to Assess Menthol Cigarette Smoker Enrollment in Quitline Services.
D'Silva J; Lien RK; Lachter R; Keller PA
Am J Prev Med; 2021 Mar; 60(3 Suppl 2):S123-S127. PubMed ID: 33663699
[TBL] [Abstract][Full Text] [Related]
12. A randomized controlled trial of potential tobacco policies prohibiting menthol flavor in cigarettes and e-cigarettes: a study protocol.
Bold KW; Sharma A; Haeny A; Gueorguieva R; Buta E; Baldassarri S; Lempert L; Krishnan-Sarin S; O'Malley S
BMC Psychiatry; 2024 Mar; 24(1):201. PubMed ID: 38475757
[TBL] [Abstract][Full Text] [Related]
13. Cessation outcomes among treatment-seeking menthol and nonmenthol smokers.
D'Silva J; Boyle RG; Lien R; Rode P; Okuyemi KS
Am J Prev Med; 2012 Nov; 43(5 Suppl 3):S242-8. PubMed ID: 23079223
[TBL] [Abstract][Full Text] [Related]
14. The impact of two state-level approaches to restricting the sale of flavored tobacco products.
Satchell T; Diaz MC; Stephens D; Bertrand A; Schillo BA; Whitsel LP
BMC Public Health; 2022 Sep; 22(1):1799. PubMed ID: 36138373
[TBL] [Abstract][Full Text] [Related]
15. A Randomized Pilot of a Tailored Smoking Cessation Quitline Intervention for Individuals Who Smoke and Vape.
Vickerman KA; Carpenter KM; Miles LN; Hsu JM; Watt KA; Brandon TH; Hart JT; Javitz HS; Wagener TL
Nicotine Tob Res; 2022 Oct; 24(11):1811-1820. PubMed ID: 35575085
[TBL] [Abstract][Full Text] [Related]
16. Utilization of a Web-based vs integrated phone/Web cessation program among 140,000 tobacco users: an evaluation across 10 free state quitlines.
Nash CM; Vickerman KA; Kellogg ES; Zbikowski SM
J Med Internet Res; 2015 Feb; 17(2):e36. PubMed ID: 25673013
[TBL] [Abstract][Full Text] [Related]
17. Prevalence and predictors of quitline enrollment following hospital referral in real-world clinical practice.
Warlick C; Richter KP; Mussulman LM; Nazir N; Patel V
J Subst Abuse Treat; 2019 Jun; 101():25-28. PubMed ID: 31174711
[TBL] [Abstract][Full Text] [Related]
18. Influence of the Flavored Cigarette Ban on Adolescent Tobacco Use.
Courtemanche CJ; Palmer MK; Pesko MF
Am J Prev Med; 2017 May; 52(5):e139-e146. PubMed ID: 28081999
[TBL] [Abstract][Full Text] [Related]
19. Enhancing tobacco quitline effectiveness: identifying a superior pharmacotherapy adjuvant.
Smith SS; Keller PA; Kobinsky KH; Baker TB; Fraser DL; Bush T; Magnusson B; Zbikowski SM; McAfee TA; Fiore MC
Nicotine Tob Res; 2013 Mar; 15(3):718-28. PubMed ID: 22992296
[TBL] [Abstract][Full Text] [Related]
20. American Indian/Alaska Native Smokers' Utilization of a Statewide Tobacco Quitline: Engagement and Quitting Behaviors From 2008 to 2018.
Lienemann BA; Cummins SE; Tedeschi GJ; Wong S; Zhu SH
Nicotine Tob Res; 2021 Jan; 23(1):219-226. PubMed ID: 31711234
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
